UPDATE 1-FDA rejects Ocular's post-operative eye pain treatment - Reuters

Review Fortune

UPDATE 1-FDA rejects Ocular's post-operative eye pain treatment Reuters (Adds details, background and share move). July 25 Drug developer Ocular Therapeutix Inc said the U.S. Food and Drug Administration had denied approval for its treatment for post-operative eye pain. The company said the FDA raised concerns related to ... SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocular Therapeutix, Inc ...PR Newswire (press release) FDA raises concerns about manufacturing deficiencies in Dextenza complete response letterHealio BTIG Remains Positive on Ocular Therapeutix (OCUL) Amid Dextenza CRLStreetInsider.com Benzinga -Mass Device -Schaeffers Research (blog) -Monthly Prescribing Reference (registration) all 23 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFxLOO5UdNC2i6K6bYgAlvWPMmgog&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779167457458&ei=zQKXV_CoAtPN3QGQubWADg&url=http://www.reuters.com/article/ocular-fda-idUSL4N1AB3SG
via IFTTT